AIkido Pharma Inc Stock price
Is AIkido Pharma Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
AIkido Pharma Inc Stock Analysis
Analyst Opinions
7 Analysts have issued a AIkido Pharma Inc forecast:
Analyst Opinions
7 Analysts have issued a AIkido Pharma Inc forecast:
Don't miss a Thing! We will send you all news about AIkido Pharma Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
AIkido Pharma Inc Stock News
Company Profile
Spherix Incorporated, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. The company's platform consists of patented technology from leading universities and researchers and in the process of developing an innovative therapeutic drug platform through partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. It has a scientific research agreement with The University of Texas Southwestern Medical Center to use machine learning to find genetic markers in people that indicate an increased risk of developing pancreatic cancer. Spherix Incorporated was founded in 1967 and is based in New York, New York.
| Head office | United States |
| CEO | Mr. Hayes |
| Employees | 36 |
| Founded | 1967 |
| Website | www.dominariholdings.com |


